Drug profile · INN
ethynodiol diacetate
OVULEN-21
ethynodiol diacetate (OVULEN-21) is a progesterone receptor agonist. Route of administration: oral-21. Current US regulatory status: approved.
Drug details — ethynodiol diacetate
- US status
- approved
- Class
- —
- Route
- ORAL-21
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
ethynodiol diacetate (OVULEN-21) is a progesterone receptor agonist. Route of administration: oral-21. Current US regulatory status: approved.
Key facts
Mechanism of action
Progesterone receptor agonist
Primary target: Progesterone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is ethynodiol diacetate?
ethynodiol diacetate (OVULEN-21) is a progesterone receptor agonist. Route of administration: oral-21. Current US regulatory status: approved.
What is the brand name for ethynodiol diacetate?
OVULEN-21 is a marketed brand name for ethynodiol diacetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ethynodiol diacetate?
ethynodiol diacetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.